| GTO ID | GTC2987 |
| Trial ID | NCT05322330 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | XPO-1 Inhibitor |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Soochow University |
| Other ID(s) | R/R B-NHL 01 |
| Cohort 1 | |||||||||||
|
|||||||||||